238 related articles for article (PubMed ID: 16595947)
1. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):470-5. PubMed ID: 16595947
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of radioiodinated 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-piperazine derivatives as new ligands for sigma receptor imaging using single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Biol Pharm Bull; 2006 Oct; 29(10):2009-15. PubMed ID: 17015942
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of [
Shigeno T; Kozaka T; Kitamura Y; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2021 Feb; 35(2):167-175. PubMed ID: 33417152
[TBL] [Abstract][Full Text] [Related]
4. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
[TBL] [Abstract][Full Text] [Related]
5. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents.
de Costa B; Radesca L; Dominguez C; Di Paolo L; Bowen WD
J Med Chem; 1992 Jun; 35(12):2221-30. PubMed ID: 1319493
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs.
Lever SZ; Xu R; Fan KH; Fergason-Cantrell EA; Carmack TL; Watkinson LD; Lever JR
Nucl Med Biol; 2012 Apr; 39(3):401-14. PubMed ID: 22172395
[TBL] [Abstract][Full Text] [Related]
8. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
12. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.
Saji H; Watanabe A; Magata Y; Ohmomo Y; Kiyono Y; Yamada Y; Iida Y; Yonekura Y; Konishi J; Yokoyama A
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):284-90. PubMed ID: 9118442
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
16. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
17. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
18. [125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Garner SE; Kung MP; Foulon C; Chumpradit S; Kung HF
Life Sci; 1994; 54(9):593-603. PubMed ID: 8114613
[TBL] [Abstract][Full Text] [Related]
19. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]